about
Effects of noradrenergic denervation by anti-DBH-saporin on behavioral responsivity to L-DOPA in the hemi-parkinsonian rat.Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats.Behavioral and cellular modulation of L-DOPA-induced dyskinesia by beta-adrenoceptor blockade in the 6-hydroxydopamine-lesioned rat.Effects of noradrenergic denervation on L-DOPA-induced dyskinesia and its treatment by α- and β-adrenergic receptor antagonists in hemiparkinsonian rats.Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian ratAlterations in primary motor cortex neurotransmission and gene expression in hemi-parkinsonian rats with drug-induced dyskinesia.The effects of BMY-14802 against L-DOPA- and dopamine agonist-induced dyskinesia in the hemiparkinsonian ratThe Role of Primary Motor Cortex (M1) Glutamate and GABA Signaling in l-DOPA-Induced Dyskinesia in Parkinsonian Rats.Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's diseaseCritical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian ratsD-512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti-Parkinsonian efficacy than ropinirole in Parkinsonian rats.Effect of tricyclic antidepressants on L-DOPA-induced dyskinesia and motor improvement in hemi-parkinsonian rats.Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
P50
Q33918393-0FAD4605-AF2E-46A2-8B8A-9054EE4D0E92Q34795714-5F8279A0-4971-43E3-A0B8-CAE4A113AFC1Q35003086-EF8B92EA-C10E-4B47-87D6-D042EDC3F4A3Q35624275-AD61388D-3965-4F7C-BDB3-3114D9EB4685Q35815701-029F7490-1A09-45A3-9993-9C1932C289FFQ36248918-A673112E-D7FB-4E86-9011-191973608B86Q36852272-56C9BE19-AFB5-4F95-A943-77061C63051DQ37270927-E486D74D-5F3E-480A-87A5-98819205A0DCQ37301208-021D7406-5FDC-4FCE-AE64-5AF303CF7938Q37385099-D93DC1C4-1ADB-4964-B85C-2EF4F7A03BCAQ37397245-DC9F3347-C803-4128-A895-E665D9A1BD62Q38699002-7D194283-DE3D-4939-8AE9-28DCF11D1568Q48960594-0B8DEDD1-C7BB-4EEE-ADF3-689F73483817Q51620020-BC79546D-A84E-44FF-A0F7-83E7808F9E26
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Lindenbach
@ast
David Lindenbach
@en
David Lindenbach
@es
David Lindenbach
@nl
type
label
David Lindenbach
@ast
David Lindenbach
@en
David Lindenbach
@es
David Lindenbach
@nl
prefLabel
David Lindenbach
@ast
David Lindenbach
@en
David Lindenbach
@es
David Lindenbach
@nl
P106
P21
P31
P496
0000-0002-9422-697X